Columbia Partners Investment Management’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-43,929
Closed -$4.7M 381
2015
Q1
$4.7M Sell
43,929
-24,447
-36% -$2.33M 0.25% 135
2014
Q4
$6.42M Buy
+68,376
New +$6.52M 0.33% 113

Other funds holding PTX

Columbia Partners Investment Management's PTX Position: Q2 2015 in Review

Columbia Partners Investment Management sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q2 2015, closing a stake of 43,929 shares — an estimated $4.7M sold.

Columbia Partners Investment Management first reported a position in PTX in Q4 2014 and held it in 2 quarters. The position peaked at $6.42M in Q4 2014. 114 funds tracked by Wall St. Rank hold PTX as of Q2 2015.

  • Columbia Partners Investment Management reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q2 2015 after selling out during the quarter.
  • Columbia Partners Investment Management sold 43,929 Pernix Therapeutics Holdings, Inc. shares in Q2 2015, an estimated $4.7M.
  • Columbia Partners Investment Management first reported a position in Pernix Therapeutics Holdings, Inc. in Q4 2014 and held it in 2 quarters.
  • Columbia Partners Investment Management's Pernix Therapeutics Holdings, Inc. position peaked at $6.42M in Q4 2014.
  • 114 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q2 2015.

Based on Columbia Partners Investment Management's 13F filing for Q2 2015, filed 5 Aug 2015.